Press
Explore Arrive Health in the news.
Our news releases cover a number of awards and recognitions, from our most recent partnerships to our impressive growth.
The Back-Office Revolution
Back-office technology that helps hospitals perform critical, everyday tasks like compiling and storing medical records, scheduling staff, reserving operating rooms, and billing patients is, by most accounts, so antiquated that it often causes more problems than it solves.
RxRevu Featured at UPMC Enterprises HIMSS19 Booth #6043
With HIMSS19 just a few days away, RxRevu is excited to announce that it will be one of UPMC Enterprises exhibiting portfolio companies.
Collaboration, Clinical Input Drive Analytics Innovation at UCHealth
As the healthcare industry comes to grips with the scale of disruption it will be facing over the next few years, a handful of forward-thinking organizations are aiming to lead the change instead of being swept along in its wake.
Health IT Developers Working to Understand Clinical Workflows
Physicians are working side-by-side with health IT developers from Google and Apple to offer insight into clinical workflows.
Doctors Ask Silicon Valley Engineers to Spend More Time in the Hospital Before Building Apps
As an emergency room physician, Richard Zane often considers how software can help him with patients. The problem is that engineers and doctors are from different worlds.
PreCheck MyScript Puts Drug Costs at Physicians’ Fingertips – in Real Time
Studies have shown a majority of doctors think cost is an important consideration in treatment, but many often don’t know the actual costs of specific treatments of prescription drugs.
At UCHealth, Rx Decision Support Nudges Physicians to Prescribe Recommended Meds
This case study looks at the electronic prescription support technology now guiding roughly 80 percent of the health system’s prescription decisions.
10 Startups Tackling the Problem of High Prescription Drug Costs
Whether by managing payments, connecting consumers to reimbursement options, or just manufacturing cheap drugs themselves, these companies are taking aim at a problem that's building to a crisis.